ImmuCell Corporation (ICCC)
NASDAQ · Healthcare
ImmuCell Corporation Net Income 2017–2025
ImmuCell Corporation annual/quarterly net income history and growth rate from 2017 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- ImmuCell Corporation net income for the quarter ending March 31, 2026 was 1.9 M, a 34.18% increase year-over-year.
- ImmuCell Corporation net income for the twelve months ending March 31, 2026 was 3.8 M, a 203.86% decrease year-over-year.
- ImmuCell Corporation annual net income for 2025 was -1.0 M, a 51.78% decrease from 2024.
- ImmuCell Corporation annual net income for 2024 was -2.2 M, a 62.65% decrease from 2023.
- ImmuCell Corporation annual net income for 2023 was -5.8 M, a 131.56% increase from 2022.
- ImmuCell Corporation annual net income for 2022 was -2.5 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
ImmuCell Corporation Net Income — FAQ
ImmuCell Corporation (ICCC) net income over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
What is ImmuCell Corporation's net income?
ImmuCell Corporation (ICCC) reported net income of -$1M for fiscal 2025.
Where can I see ICCC's net income history?
The chart and table above show ImmuCell Corporation's net income by year and by quarter, including the growth rate.